Corona Virus Disease 2019
Conditions
Interventions
experimental group:Qingjin Yiqi granules
Control group:Placebo
Sponsors
Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for novel coronavirus infection (Diagnosis and Treatment Protocol for novel Coronavirus Infection (trial version 10)); 2. Positive nucleic acid/antigen test results or positive IgM test results within 2 months 3. Qiyinliangxu, Yureweiqing type 4. Age > 18 years old; 5. Borg Scale >= 15 points; 6. Informed consent of the patient.
Exclusion criteria
Exclusion criteria: 1. Patients with severe lung diseases, such as lung tumor, severe chronic obstructive pulmonary disease, lung transplantation, lung resection, lung volume reduction, etc.; 2. with serious underlying diseases that affect survival, including uncontrolled heart, kidney, digestive, hematological, neuropsychiatric, immune, metabolic, malignant tumors, severe malnutrition, etc.; 3. Allergic constitution, allergic to the drug ingredients involved in the treatment plan; 4. Pregnant or lactating women; 5. Participants in other clinical trials; 6. According to the judgment of the investigators, there will be patients with complications in enrollment or poor compliance, which will affect the evaluation of efficacy and safety.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Borg scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome score;Disappearance rate of single symptom;6-minute walk test;Cough scale;Modified Medical Research Council (mMRC) scale;inflammatory factor;Adverse event; | — |
Countries
China
Contacts
Public ContactZheng Wenke
Tianjin University of Traditional Chinese Medicine
Outcome results
None listed